Join
Live feed
·
INSIDERFilingvia Quantisnow
Clovis Oncology Inc. logo

SEC Form 4: Muehl Daniel W converted options into 10,249 shares and sold $6,799 worth of shares (4,654 units at $1.46), increasing direct ownership by 6% to 96,332 units (tax liability)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLVS (Clovis Oncology Inc.) and more on Quantisnow.